SMPNY Financial Statements & Analysis
Complete financial statements for SMPNY including income statement, balance sheet, and cash flow statement. Analyze SMPNY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
25.7% ↑
Net Income
179.1% ↑
Gross Margin
0.0% ↓
Operating Margin
115.4% ↑
Balance Sheet
Current Ratio
231.0% ↑
Debt to Equity
-11.9% ↑
Asset Turnover
6.9% ↑
Cash Flow
Operating Cash Flow
30.7% ↑
Net Cash Flow
276.6% ↑
Free Cash Flow
38.2% ↑
Cash Flow to Debt
20.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2025 | 2026 | Change | Impact |
|---|---|---|---|---|
| Revenue | 5.25T | 6.60T | 25.7% | |
| Gross Profit | 5.25T | 6.60T | 25.7% | |
| Operating Income | 330.28B | 894.08B | 170.7% | |
| Net Income | 243.13B | 678.69B | 179.1% | |
| EPS | 125.46 | 372.29 | 196.7% | |
| EBITDA | 451.67B | 1.03T | 128.9% | |
| Gross Margin | 100.00% | 100.00% | 0.0% | |
| Operating Margin | 6.29% | 13.54% | 115.4% | |
| Net Income Margin | 4.63% | 10.28% | 122.1% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 6.60T | 5.25T | 5.35T | — | — |
| Gross Profit | 6.60T | 5.25T | 4.60T | — | — |
| Operating Income | 894.08B | 330.28B | 614.53B | — | — |
| Net Income | 678.69B | 243.13B | 529.65B | — | — |
| EPS | 372.29 | 125.46 | 209.85 | — | — |
| EBITDA | 1.03T | 451.67B | 722.78B | — | — |
| Gross Margin | 100.00% | 100.00% | 85.91% | — | — |
| Operating Margin | 13.54% | 6.29% | 11.48% | — | — |
| Net Income Margin | 10.28% | 4.63% | 9.89% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into SMPNY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics